Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Acadia Pharmaceutica (NQ: ACAD ) 16.74 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Apr 23, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Acadia Pharmaceutica < Previous 1 2 3 4 5 6 7 8 9 ... 12 13 Next > Acadia Pharmaceuticals Announces Trofinetide New Drug Submission for Treatment of Rett Syndrome Has Been Accepted for Filing and Priority Review by Health Canada April 22, 2024 From Acadia Pharmaceuticals Inc. Via Business Wire Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) April 19, 2024 From Acadia Pharmaceuticals Inc. Via Business Wire Acadia Pharmaceuticals Presents New DAYBUE™ (trofinetide) Clinical Data at the 2024 American Academy of Neurology (AAN) Annual Meeting April 17, 2024 From Acadia Pharmaceuticals Inc. Via Business Wire 3 Pharma Stocks to Sell in April Before They Crash & Burn April 11, 2024 Discover three pharma stocks to sell in April, facing challenges and signaling potential for significant downside. Via InvestorPlace Cracking The Code: Understanding Analyst Reviews For ACADIA Pharmaceuticals April 10, 2024 Via Benzinga Expert Ratings For ACADIA Pharmaceuticals March 25, 2024 Via Benzinga Beyond The Numbers: 13 Analysts Discuss ACADIA Pharmaceuticals Stock February 28, 2024 Via Benzinga Acadia Appoints Elizabeth H. Z. Thompson, Ph.D. as Executive Vice President, Head of Research and Development April 02, 2024 From Acadia Pharmaceuticals Inc. Via Business Wire Acadia Pharmaceuticals to Participate in the 23rd Annual Needham Virtual Healthcare Conference April 01, 2024 From Acadia Pharmaceuticals Inc. Via Business Wire 10 Health Care Stocks With Whale Alerts In Today's Session March 19, 2024 Via Benzinga Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) March 15, 2024 From Acadia Pharmaceuticals Inc. Via Business Wire Recap: ACADIA Pharmaceuticals Q4 Earnings February 27, 2024 Via Benzinga 3 Pharma Stocks to Sell in March Before They Crash & Burn March 14, 2024 Discover top pharma stocks to sell in March before they plummet. Learn why ACAD, AMLX and WST are on the list for urgent sell-off decisions. Via InvestorPlace Acadia Pharmaceuticals to Participate in the UBS Virtual CNS Day March 13, 2024 From Acadia Pharmaceuticals Inc. Via Business Wire Why Are Airline Stocks Down Today? March 12, 2024 Airline stocks are down on Tuesday as investors deal with several bits of bad news for the industry on Tuesday! Via InvestorPlace Why Is Acadia Pharmaceuticals (ACAD) Stock Down 18% Today? March 12, 2024 Acadia Pharmaceuticals stock is falling on Tuesday as investors in ACAD react to its failed Phase 3 clinical trial of pimavanserin. Via InvestorPlace Oracle To Rally Around 40%? Here Are 10 Top Analyst Forecasts For Tuesday March 12, 2024 Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Via Benzinga Why Asana Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session March 12, 2024 Shares of Asana, Inc. (NYSE: ASAN) fell sharply during Tuesday’s session following soft FY25 revenue guidance. Via Benzinga Acadia Hits 11-Month Low After Outsized Placebo Effect Torpedoes Schizophrenia Study March 12, 2024 The company says it doesn't plan to further develop Nuplazid in clinical testing. Via Investor's Business Daily 12 Health Care Stocks Moving In Tuesday's Pre-Market Session March 12, 2024 Via Benzinga Why Oracle Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket March 12, 2024 Shares of Oracle Corporation (NYSE: ORCL) rose sharply in today’s pre-market trading after the company reported upbeat earnings for its fis Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday March 12, 2024 Pre-market stock movers are worth checking out this morning as we get into all of the biggest winners and losers for Tuesday! Via InvestorPlace Trial Setback For Acadia Pharmaceuticals' Late-Stage Schizophrenia Trial: Details March 12, 2024 Acadia Pharmaceuticals' Phase 3 ADVANCE-2 trial results on pimavanserin for schizophrenia-negative symptoms. Insights on efficacy, safety, and future considerations. Via Benzinga ACADIA Pharmaceuticals, Ocular Therapeutix, Asana And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session March 12, 2024 U.S. stock futures were mixed this morning, with the Nasdaq futures gaining by around 50 points on Tuesday. Via Benzinga 12 Health Care Stocks Moving In Monday's After-Market Session March 11, 2024 Via Benzinga Acadia Pharmaceuticals Announces Top-Line Results from Phase 3 ADVANCE-2 Trial of Pimavanserin in Negative Symptoms of Schizophrenia March 11, 2024 From Acadia Pharmaceuticals Inc. Via Business Wire 3 Stock Winners That Are Up 1,000% or More in 2024 March 08, 2024 Dig deep enough, and find a story hot enough, and you can uncover potential stock winners up 1,000%. Here are three. Via InvestorPlace Acadia Pharmaceuticals to Participate in TD Cowen’s 44th Annual Health Care Conference on March 6, 2024 February 29, 2024 From Acadia Pharmaceuticals Inc. Via Business Wire Acadia Stock Dives As Unexpected Seasonality Rocks Its Most High-Profile Launch February 28, 2024 CEO Steve Davis said there was a lot of pent-up demand when Daybue first launched last year. Via Investor's Business Daily Acadia Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operating Overview February 27, 2024 From Acadia Pharmaceuticals Inc. Via Business Wire < Previous 1 2 3 4 5 6 7 8 9 ... 12 13 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.